Circulatory System
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adult patients (=18 years) with a confirmed diagnosis of HFrEF (LVEF =40% on echocardiography) 2. Who are clinically stable for at least 4 weeks with no recent hospitalizations 3. Are on guideline directed optimum therapy. with no changes in HF medication 4. NYHA functional class II-III, 5. Provision of informed consent
Exclusion criteria
Exclusion criteria: 1. Severe comorbid conditions, Unstable angina, significant arrhythmias, severe orthopaedic or neurological conditions limiting exercise participation, 2. Significant cognitive impairment, 3. Planned cardiac surgery or intervention during study period 4. Presence of Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in functional capacity (6-Minute Walk Distance) between an intervention group receiving CR and a control group receiving usual care over 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in health-related quality of life (using the Kansas City Cardiomyopathy Questionnaire (KCCQ)) between the two groups over 12 weeks. 2. The rate of all-cause hospital readmissions between the two groups at a 6-month follow-up 3. Explore the experiences, barriers, and facilitators of participating in the CR programme. | — |
Countries
Nigeria
Contacts
Cardiologist